LWW to publish AANN’s journal

Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer Health, has signed an agreement with the American Association of Neuroscience Nurses's official journal.

November 15, 2008

10:37 pm

Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer Health, has signed an agreement with the American Association of Neuroscience Nurses’s official journal, the Journal of Neuroscience Nursing (JNN).

The journal offers content across diverse areas of neuroscience patient care, and is applicable to healthcare professionals working in clinical, research, administrative and educational settings, according to a company statement.

“We are excited about the wonderful opportunities that await us with our partnership with LWW,” said V. Susan Carroll, JNN‘s editor, in the statement.

From the December 01, 2008 Issue of MM+M - Medical Marketing and Media

From Our Partners

How AI and first-party data is transforming pharma customer engagement

Partner Content

How AI and first-party data is transforming pharma customer engagement

Using technology to improve audience segmentation, targeting and virtual interaction.

The importance of female representation in health

Partner Content

The importance of female representation in health

How to effect change and close the gender gap in healthcare.

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Partner Content

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Listen to Jack O’Brien of MM+M and Brandon Pletsch, president of scientific visualization at Real Chemistry, as they delve into the dynamic intersection of art, science and AI innovation in the field of scientific visualization.

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs

Partner Content

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs

This session with Justin Freid, chief marketing and innovation officer of CMI Media Group, and Daniel Nadler, founder of Open Evidence, will enlighten health brands to the possibilities of AI.